Trials / Conditions / B-Cell Neoplasm
B-Cell Neoplasm
7 registered clinical trials studyying B-Cell Neoplasm — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell N NCT06508931 | Miltenyi Biomedicine GmbH | Phase 2 |
| Not Yet Recruiting | Systemic Inflammatory Markers in B-cell Neoplasm NCT06847529 | Assiut University | — |
| Recruiting | Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas NCT05389423 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 201 NCT04665115 | Academic and Community Cancer Research United | Phase 2 |
| Completed | Vaccine Responsiveness After CAR-T Cell Therapy NCT04410900 | Fred Hutchinson Cancer Center | Phase 1 |
| Active Not Recruiting | Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-ass NCT02911142 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | 18F-FSPG PET/CT for Cancer Patients on Therapy NCT02599194 | Andrei Iagaru | Phase 2 |